Symptom pattern following a meal challenge test in patients with irritable bowel syndrome and healthy controls

United European Gastroenterology Journal

Volumn 1, Issue 5, 2013, Pages 358-367

  Posserud, Iris ^a   Strid, Hans ^a   Störsrud, Stine ^a   Törnblom, Hans ^a   Svensson, Ulla ^b   Tack, Jan ^c   Van Oudenhove, Lukas ^c   Simrén, Magnus ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b Arla Foods Innovation   (Sweden)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Irritable bowel syndrome; Meal test; Postprandial symptoms; Visceral hypersensitivity

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; BODY MASS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; EPIGASTRIC FULLNESS; FEMALE; FLATULENCE; HUMAN; HYPERSENSITIVITY; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM ASSESSMENT; VISUAL ANALOG SCALE;

EID: 85006212951     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640613501817     Document Type: Article

References (47)

1. Lovell RM and Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721.
2. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl 2): 243-247.
3. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491.
4. Ohman L and Simren M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 2007; 39: 201-215.
5. Camilleri M, Coulie B and Tack JF. Visceral hypersensitivity: Facts, speculations, and challenges. Gut 2001; 48: 125-131.
6. Whitehead WE and Palsson OS. Is rectal pain sensitivity a biological marker for irritable bowel syndrome: Psychological influences on pain perception. Gastroenterology 1998; 115: 1263-1271.
7. Naliboff BD, Berman S, Suyenobu B, et al. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006; 131: 352-365.
8. Nanda R, James R, Smith H, et al. Food intolerance and the irritable bowel syndrome. Gut 1989; 30: 1099-1104.
9. Dainese R, Galliani EA, De Lazzari F, et al. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients. Am J Gastroenterol 1999; 94: 1892-1897.
10. Simren M, Mansson A, Langkilde AM, et al. Foodrelated gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001; 63: 108-115.
11. Elsenbruch S, Lovallo WR and Orr WC. Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome. Psychosom Med 2001; 63: 805-813.
12. Ragnarsson G and Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS). Patients’ description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol 1998; 10: 415-421.
13. Monsbakken KW, Vandvik PO and Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome—etiology, prevalence and consequences. Eur J Clin Nutr 2006; 60: 667-672.
14. Posserud I, Syrous A, Lindstrom L, et al. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007; 133: 1113-1123.
15. Simren M, Abrahamsson H and Bjornsson ES. Lipidinduced colonic hypersensitivity in the irritable bowel syndrome: The role of bowel habit, sex, and psychologic factors. Clin Gastroenterol Hepatol 2007; 5: 201-208.
16. Simren M, Abrahamsson H and Bjornsson ES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome. Gut 2001; 48: 20-27.
17. Caldarella MP, Milano A, Laterza F, et al. Visceral sensitivity and symptoms in patients with constipation-or diarrhea-predominant irritable bowel syndrome (IBS): Effect of a low-fat intraduodenal infusion. Am J Gastroenterol 2005; 100: 383-389.
18. Sullivan MA, Cohen S and Snape WJ. Colonic myoelectrical activity in irritable-bowel syndrome. Effect of eating and anticholinergics. N Engl J Med 1978; 298: 878-883.
19. Vassallo MJ, Camilleri M, Phillips SF, et al. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc 1992; 67: 725-731.
20. Di Stefano M, Miceli E, Missanelli A, et al. Meal induced rectosigmoid tone modification: A low caloric meal accurately separates functional and organic gastrointestinal disease patients. Gut 2006; 55: 1409-1414.
21. Chey WY, Jin HO, Lee MH, et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001; 96: 1499-1506.
22. Simren M, Castedal M, Svedlund J, et al. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS). Dig Dis Sci 2000; 45: 2151-2161.
23. Park MI and Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006; 18: 595-607.
24. Rumessen JJ and Gudmand-Høyer E. Functional bowel disease: Malabsorption and abdominal distress after ingestion of fructose, sorbitol, and fructose-sorbitol mixtures. Gastroenterology 1988; 95: 694-700.
25. King TS, Elia M and Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998; 352: 1187-1189.
26. Salvioli B, Serra J, Azpiroz F and Malagelada JR. Impaired small bowel gas propulsion in patients with bloating during intestinal lipid infusion. Am J Gastroenterol 2006; 101: 1853-1857.
27. Serra J, Salvioli B, Azpiroz F, et al. Lipid-induced intestinal gas retention in irritable bowel syndrome. Gastroenterology 2002; 123: 700-706.
28. Halpert A and Drossman D. Biopsychosocial issues in irritable bowel syndrome. J Clin Gastroenterol 2005; 39: 665-669.
29. Ng C, Malcolm A, Hansen R, et al. Feeding and colonic distension provoke altered autonomic responses in irritable bowel syndrome. Scand J Gastroenterol 2007; 42: 441-446.
30. Elsenbruch S, Holtmann G, Oezcan D, et al. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol 2004; 99: 703-710.
31. Van Der Veek PP, Biemond I and Masclee AA. Proximal and distal gut hormone secretion in irritable bowel syndrome. Scand J Gastroenterol 2006; 41: 170-177.
32. Simren M, Stotzer PO, Sjövall H, et al. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome. Eur J Gastroenterol Hepatol 2003; 15: 55-62.
33. Tack J, Caenepeel P, Piessevaux H, et al. Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia. Gut 2003; 52: 1271-1277.
34. Cuomo R, Sarnelli G, Grasso R, et al. Functional dyspepsia symptoms, gastric emptying and satiety provocative test: Analysis of relationships. Scand J Gastroenterol 2001; 36: 1030-1036.
35. Montano-Loza A, Schmulson M, Zepeda-Gomez S, et al. Maximum tolerated volume in drinking tests with water and a nutritional beverage for the diagnosis of functional dyspepsia. World J Gastroenterol 2005; 11: 3122-3126.
36. Becker W and Pearsson M. Riksmaten 1997-98. Dietary habits and nutrient intake in SwedenUppsala: National Food Administration, 2002.
37. Francis CY, Morris J and Whorwell PJ. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
38. Rome II Modular Questionnaire: Investigator and respondent forms. In: Drossman DA, Corazziari E, Talley NJ, et al. (eds) Rome II: The functional gastrointestinal disorders. 2nd ed. McLean, VA, USA: Degnon Associates, 2000, pp.669-688.
39. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2): 237-242.
40. Arts J, Caenepeel P, Verbeke K, et al. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying. Gut 2005; 54: 455-460.
41. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Ther 2005; 22: 847-853.
42. Tack J, Janssen P, Masaoka T, et al. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10: 1239-1245.
43. Jerndal P, Ringström G, Agerforz P, et al. Gastrointestinal-specific anxiety: An important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol Motil 2010; 22: e646-e179.
44. Posserud I, Svedlund J, Wallin J, et al. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease. J Psychosom Res 2009; 66: 399-405.
45. Van Oudenhove L, Vandenberghe J, Vos R, et al. Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia. Neurogastroenterol Motil 2011; 23: e524-e202.
46. Tornblom H, Van Oudenhove L, Sadik R, et al. Colonic transit time and IBS symptoms: What’s the link? Am J Gastroenterol 2012; 107: 754-760.
47. Jeffery IB, O’Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61: 997-1006.